Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 35, Issue 11, 1996, Pages 1491-1501

  Wilens, Timothy E ^a   Biederman, Joseph ^a   Baldessarini, Ross J ^a   Geller, Barbara ^b   Schleifer, David ^a   Spencer, Thomas J ^a   Birmaher, Boris ^c   Goldblatt, Alan ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

adolescents; cardiovascular; children; electrocardiography; tricyclic antidepressants

Indexed keywords

AMITRIPTYLINE; DESIPRAMINE; IMIPRAMINE; NORTRIPTYLINE;

ARTICLE; CARDIOVASCULAR DISEASE; CHILD; DRUG BLOOD LEVEL; DRUG EFFECT; HEART CONDUCTION; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; SUDDEN DEATH; SYSTOLIC BLOOD PRESSURE;

EID: 0029835429     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-199611000-00018     Document Type: Article

References (80)

1. Ambrosini PJ, Bianchi MD, Rabinovich H, Elia J (1993), Antidepressant treatments in children and adolescents: I. Affective disorders. J Am Acad Child Adolesc Psychiatry 32:1-6
2. Anderson JC, Williams S, McGee R, Silva PA (1987), DSM-III disorders in preadolescent children. Arch Gen Psychiatry 44:69-76
3. Baldessarini RJ (1996), Chemotherapy in Psychiatry. Cambridge, MA: Harvard University Press
4. Bartels MG, Varley CK, Mitchell J, Stamm SJ (1991), Pediatric cardiovascular effects of imipramine and desipramine. J Am Acad Child Adolesc Psychiatry 30:100-103
5. Bernstein GA, Borchardt CM (1991), Anxiety disorders of childhood and adolescence: a critical review. J Am Acad Child Adolesc Psychiatry 30:519-532
6. Bertilsson L, Mellstrom B, Sjoqvist F (1979), Pronounced inhibition of noradrenaline uptake by 10-hydroxy-metabolites of nortriptyline. Life Sci 25:1285-1292
7. Biederman J (1991), Sudden death in children treated with a tricyclic antidepressant. J Am Acad Child Adolesc Psychiatry 30:495-498
8. Biederman J, Baldessarini RJ, Goldblatt A, Lapey KA, Doyle A, Hesslein PS (1993), A naturalistic study of 24-hour electrocardiographic recordings and echocardiographic findings in children and adolescents treated with desipramine. J Am Acad Child Adolesc Psychiatry 32:805-813
9. Biederman J, Baldessarini RJ, Wright V, Knee D, Harmatz JS, Goldblatt A (1989), A double-blind placebo controlled study of desipramine in the treatment of ADD: II. Serum drug levels and cardiovascular findings. J Am Acad Child Adolesc Psychiatry 28:903-911
10. Biederman J, Gastfriend D, Jellinek MS, Goldblatt A (1985), Cardiovascular effects of desipramine in children and adolescents with attention deficit disorder. J Pediatr 106:1017-1020
11. Biederman J, Thisted RA, Greenhill L, Ryan N (1995), Estimation of the association between desipramine and the risk for sudden death in 5-to 14-year old children. J Clin Psychiatry 56:87-93
12. Costello EJ (1989), Developments in child psychiatry epidemiology. J Am Acad Child Adolesc Psychiatry 28:836-841
13. Dell RB, Hein K, Ramakrishnan R, Puig-Antich J, Cooper T (1990), Model for the kinetics of imipramine and its metabolites in adolescents. Ther Drug Monit 12:450-459
14. Dickinson DF, Scott O (1984), Ambulatory electrocardiographic monitoring in 100 healthy teenage boys. Br Heart J 51:179-183
15. Donnelly M, Zametkin AJ, Rapoport JL (1986), Treatment of childhood hyperactivity with desipramine: plasma drug concentration, cardiovascular effects, plasma and urinary catecholamine levels, and clinical response. Clin Pharmacol Ther 39:72-81
16. Fava M, Rosenbaum JF (1992), Research Designs and Methods in Psychiatry. New York: Elsevier
17. Fletcher SE, Case CL, Sallee FR, Hand LD, Gillette PC (1993), Prospective study of the electrocardiographic effects of imipramine in children. J Pediatr 122:652-654
18. Fletcher SE, Case CL, Williamson CE, Gillette PC, Bucklee DS, Hewett KW (1992), Developmental electrophysiologic properties of imipramine. Presented at American Heart Association, 65th Annual Scientific Sessions, New Orleans
19. Garson A, Bricker JT, McNamara DG (1990), The Science and Practice of Pediatric Cardiology, Vois 1-3. Philadelphia: Lea & Febiger
20. Geller B (1991), Commentary on unexplained deaths of children on Norpramin. J Am Acad Child Adolesc Psychiatry 30:682-684
21. Geller B, Cooper TB, Chestnut EC (1985a), Serial monitoring and achievement of steady state nortriptyline plasma levels in depressed children and adolescents. J Clin Psychopharmacol 5:213-216
22. Geller B, Cooper TB, Graham DL, Fetner HH, Marsteller FA, Wells JM (1992), Pharmacokinetically designed double-blind placebo-controlled study of nortriptyline in 6-to 12-year-olds with major depressive disorder. J Am Acad Child Adolesc Psychiatry 31:34-44
23. Geller B, Cooper TB, Graham DL, Marsteller FA, Bryant DM (1990), Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a "fixed plasma level" design. Psychopharmacol Bull 26:85-90
24. Geller B, Farooki ZQ, Cooper TB, Chestnut EC, Abel AS (1985b), Serial ECG measurements at controlled plasma levels of nortriptyline in depressed children. Am J Psychiatry 142:1095-1097
25. Giardina EV, Bigger TJ, Glassman AH, Perel JM, Kantor SJ (1979), The electrocardiographic and antiarrhythmic effects of imipramine hydrochloride at therapeutic plasma concentrations. Circulation 60:1045-1052
26. Glassman AH, Roose SP, Giardina EV, Bigger JT (1987), Cardiovascular effects of tricyclic antidepressants. In: Psychopharmacology: The Third Generation of Progress, Meltzer HY, ed. New York: Raven Press, pp 1437-1442
27. Hayes TA, Panitch ML, Barker E (1975), Imipramine dosage in children: a comment on imipramine and electrocardiographic abnormalities in hyperactive children. Am J Psychiatry 132:545-547
28. Jandhyala BS, Steenberg ML, Perel JM, Manian AA, Buckley JP (1977), Effects of several tricyclic antidepressants on the hemodynamics and myocardial contractibility of the anesthetized dogs. Eur J Pharmacol 42:403-410
29. Kagan J, Reznick JS, Snidman N (1987), The physiology and psychiatry of behavioral inhibition in children. Child Dev 58:1459-1473
30. Kapur S, Mieczkowski T, Mann J (1992), Antidepressant medications and the relative risk of suicide attempt and suicide. JAMA 268:5441-5445
31. Krawkowski AJ (1965), Amitriptyline in treatment of hyperkinetic children. Psychosomatics 6:611-614
32. Leonard HL, Meyer MC, Swedo SE et al. (1995), Electrocardiographic changes during desipramine and clomipramine treatment in children and adolescents. J Am Acad Child Adolesc Psychiatry 34:1460-1468
33. Leonard HL, Rapoport JL (1989), Pharmacotherapy of childhood obsessive-compulsive disorder. Psychiatr Clin North Am 12:963-970
34. Leonard HL, Swedo SE, Rapoport JL et al. (1989), Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. Arch Gen Psychiatry 46:1088-1092
35. Martin GI, Zaug PJ (1973), ECG monitoring of enuretic children given imipramine. JAMA 224:902-903
36. Medical Letter (1990), Sudden death in children treated with a tricyclic antidepressant. 32:53
37. Meredith IT, Broughton A, Jennings GL, Esler MD (1991), Evidence of a selective increase in sympathetic activity in patients with sustained ventricular arrhythmias. N Engl J Med 325:618-624
38. Morselli PL (1977), Psychotropic drugs. In: Drug Disposition during Development, Morselli P, ed. New York: Spectrum, pp 431-474
39. Park MK (1988), Pediatric Cardiology for Practitioners. Chicago: Year Book Medical Publishers
40. Pfeifer MA, Weinberg CR, Cook D, Best JD, Reenan A, Halter JB (1983), Differential changes of autonomic nervous system function with age in man. Am J Med 75:249-258
41. Pollock BG, Perel JM (1989), Hydroxy metabolites of tricyclic antidepressants: evaluation of relative cardiotoxicity. In: Clinical Pharmacology in Psychiatry (Psychopharmacology Series 7), Dahl SG, Gram LF, eds. Berlin: Springer-Verlag, pp 232-236
42. Popper C (1993), Simon Wile Symposium: sudden death on antidepressants. In: Scientific Proceedings of the American Academy of Child and Adolescent Psychiatry, San Antonio, TX, 9:24
43. Popper C, Elliot GR (1993), Postmortem pharmacokinetics of tricyclic antidepressants: are some deaths during treatment misattributed to overdose? J Child Adolesc Psychopharmacol 3:10-12
44. Potter WZ, Calil HM, Sutfin TA et al. (1982), Active metabolites of imipramine and desipramine in man. Clin Pharmacol Ther 31:393-401
45. Poussaint AF, Ditman KS (1965), A controlled study of imipramine (Tofranil) in the treatment of childhood enuresis. J Pediatr 67:283-289
46. Preskorn SH, Weller EB, Weller RA (1982), Depression in children: relationship between plasma imipramine levels and response. J Clin Psychiatry 43:450-453
47. Preskorn SH, Weller EB, Weller RA, Glotzbach E (1983), Plasma levels of imipramine and adverse effects in children. Am J Psychiatry 140:1332-1335
48. Puig-Antich J, Perel JM, Lupatkin W et al. (1979), Plasma levels of imipramine (IMI) and desmethylimipramine (DMI) and clinical response in prepubertal major depressive disorder. J Am Acad Child Psychiatry 18:616-627
49. Puig-Antich J, Perel JM, Lupatkin W et al. (1987), Imipramine in prepubertal major depressive disorders. Arch Gen Psychiatry 44:81-89
50. Rapoport J (1965), Childhood behavior and learning problems treated with imipramine. Int J Neuropsychiatry 1:635-642
51. Rapoport JL, Quinn PO, Bradbard G, Riddle D, Brooks E (1974), Imipramine and methylphenidate treatments of hyperactive boys. Arch Gen Psychiatry 30:789-793
52. Riddle M (1994), Forensic issues in tricyclic antidepressants in children and adolescents. Institute on Advanced Topics in Psychopharmacology. Presented at the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, New York, October
53. Riddle M, Geller B, Ryan N (1993), Another sudden death in a child treated with desipramine. J Am Acad Child Adolesc Psychiatry 32:792-797
54. Riddle MA, Nelson JC, Kleinman CS et al. (1991), Sudden death in children receiving Norpramin: a review of three reported cases and commentary. J Am Acad Child Adolesc Psychiatry 30:104-108
55. Roose SP, Glassman AH (1989), Cardiovascular effects of tricyclic antidepressants in depressed patients. J Clin Psychiatry 7:1-18
56. Rosenberg D, Holttum J, Gershon S (1994), Textbook of Pharmacotherapy for Child and Adolescent Psychiatric Disorders. New York: Brunner/Mazel
57. Ryan N, Puig-Antich J, Ambrosini P et al. (1987a), The clinical picture of major depression in children and adolescents. Arch Gen Psychiatry 44:854-861
58. Ryan ND, Dahl RE (1993), Neurobiology of depression in children and adolescents. Clin Neurosci 1:108-112
59. Ryan ND, Puig-Antich J, Cooper TB et al. (1987b), Relative safety of single versus divided dose imipramine in adolescent major depression. J Am Acad Child Adolesc Psychiatry 26:400-406
60. Saraf KR, Klein DF, Gittelman-Klein R, Gootman N, Greenhill P (1978), EKG effects of imipramine treatment in children. J Am Acad Child Psychiatry 17:60-69
61. Schroeder JS, Mullin AV, Elliott GR et al. (1989), Cardiovascular effects of desipramine in children. J Am Acad Child Adolesc Psychiatry 28:376-379
62. Scott O, Williams GJ, Fiddler GI (1980), Results of 24 hour ambulatory monitoring of electrocardiogram in 131 healthy boys aged 10 to 13 years. Br Heart J 44:304-308
63. Silber EN, Katz LN (1975), Heart Disease. New York: MacMillan
64. Singer HV, Brown J, Quaskey S, Rosenberg LA, Mellits ED, Denckla M (1995), The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo controlled study with clonidine and desipramine. Pediatrics 95:74-81
65. Southall DP, Johnston F, Shinebourne EA, Johnston PG (1981), 24-Hour electrocardiographic study of heart rate and rhythm patterns in population of healthy children. Br Heart J 45:281-291
66. Spencer T, Biederman J, Wilens T, Harding M, O'Donnell D, Griffin S (1996), Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 35:409-432
67. Urman R, Ickowicz A, Fulford P, Tannock R (1995), An exaggerated cardiovascular response to methylphenidate in ADHD children with anxiety. J Child Adolesc Psychopharmacol 5:29-37
68. Van Ravenswaaij-Arts CMA, Kollee LAA, Hopman JCW, Stoelinga GVA, Van Geijn HP (1993), Heart rate variability. Ann Intern Med 118: 436-447
69. Waizer J, Hoffman SP, Polizos P (1974), Outpatient treatment of hyperactive school children with imipramine. Am J Psychiatry 131:587-591
70. Walsh BT, Giardina EV, Sloan RP, Greenhill L, Goldfein J (1994), Effects of desipramine on autonomic control of the heart. J Am Acad Child Adolesc Psychiatry 33:191-197
71. Werry J (1995), Cardiac arrhythmias make desipramine an unacceptable choice in children. J Am Acad Child Adolesc Psychiatry 35:1239-1241
72. Wight JN, Salem D (1995), Sudden cardiac death and the "athlete's heart." Arch Intern Med 155:1473-1480
73. Wilens TE, Biederman J, Baldessarini RJ, Puopolo P, Flood J (1992), Developmental changes in serum concentrations of desipramine and 2-hydroxydesipramine during treatment with desipramine. J Am Acad Child Adolesc Psychiatry 31:691-699
74. Wilens TE, Biederman J, Baldessarini RJ, Puopolo PR, Flood JG (1993a), Electrocardiographic effects of desipramine and 2-hydroxydesipramine in children, adolescents, and adults treated with desipramine. J Am Acad Child Adolesc Psychiatry 32:798-804
75. Wilens TE, Biederman J, Spencer T, Geist DE (1993b), A retrospective study of serum levels and electrocardiographic effects of nortriptyline in children and adolescents. J Am Acad Child Adolesc Psychiatry 32:270-277
76. Winsberg BG (1975), Imipramine and electrocardiographic abnormalities in hyperactive children. Am J Psychiatry 132:542-547
77. Winsberg BG, Bialer I, Kupietz S, Tobias J (1972), Effects of imipramine and dextroamphetamine on behavior of neuropsychiatrically impaired children. Am J Psychiatry 128:1425-1431
78. Young RC, Alexopoulos GS, Shamoian CA, Manley MW, Dhar AK, Kutt H (1984), Plasma 10-hydroxynortriptyline in elderly depressed patients. Clin Pharmacol Ther 35:540-544
79. Ziegler VE, Co BT, Biggs JH (1977), Plasma nortriptyline levels and ECG findings. Am J Psychiatry 134:441-443
80. Zipes DP (1991), Sympathetic stimulation and arrhythmias. N Engl J Med 325:656-657